Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Accounts Payables (2020 - 2026)

GeneDx Holdings has reported Accounts Payables over the past 7 years, most recently at $46.6 million for Q1 2026.

  • Quarterly Accounts Payables rose 11.23% to $46.6 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $46.6 million through Mar 2026, up 11.23% year-over-year, with the annual reading at $57.6 million for FY2025, 86.05% up from the prior year.
  • Accounts Payables was $46.6 million for Q1 2026 at GeneDx Holdings, down from $57.6 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $115.9 million in Q2 2022 and troughed at $31.0 million in Q4 2024.
  • The 5-year median for Accounts Payables is $52.0 million (2024), against an average of $57.3 million.
  • Year-over-year, Accounts Payables surged 156.19% in 2022 and then plummeted 55.87% in 2023.
  • A 5-year view of Accounts Payables shows it stood at $84.9 million in 2022, then crashed by 55.87% to $37.5 million in 2023, then fell by 17.28% to $31.0 million in 2024, then surged by 86.05% to $57.6 million in 2025, then dropped by 19.23% to $46.6 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Accounts Payables are $46.6 million (Q1 2026), $57.6 million (Q4 2025), and $50.3 million (Q3 2025).